When did Integra LifeSciences report Q2 2024 earnings?

Integra LifeSciences (IART) reported Q2 2024 earnings on July 29, 2024 before market open.

What were Integra LifeSciences's Q2 2024 revenue and EPS?

Integra LifeSciences reported revenue of $418.2M and eps of $0.63 for Q2 2024.

Did Integra LifeSciences beat estimates in Q2 2024?

Revenue beat the consensus estimate of $413.2M by $5.0M. EPS beat the consensus estimate of $0.62 by $0.01.

Where can I find Integra LifeSciences's Q2 2024 SEC filings?

You can read the 10-Q periodic report (0000917520-24-000094) directly on SEC EDGAR. The filing index links above go to sec.gov.

Integra LifeSciences IART Q2 2024 earnings

Reported July 29, 2024 · Before market open

Revenue$418.2MBeat by $5.0M

EPS$0.63Beat by $0.01

Revenue estimate$413.2M

EPS estimate$0.62

Next report

Jul 29, 2026 (Today)

Revenue estimate$417.5M

EPS estimate$0.48

View report

Financials

Q2 2024

Income statement

See full

Revenue$418.2M+9.7%

Gross profit$225.9M+9.1%

Operating income-$3.0M-124%

Net income-$12.4M-396%

EPS (diluted)-$0.16-420%

Balance sheet

See full

Cash & equivalents$215.2M-30.4%

Total debt$1.4B+43.7%

Total equity$1.5B-8.9%

Total assets$4.1B+7.9%

Cash flow

See full

Operating cash flow$40.4M+42.9%

CapEx$29.7M+91.1%

Free cash flow$10.7M-16.0%

Valuation & ratios

Valuation

as of 06/30/24

See full

Market cap$2.27B-30.9%

Enterprise value$3.42B-12.8%

P/E95.8×+70.8×

P/S1.4×-0.7×

Profitability

See full

Gross margin56%-3.9pp

Operating margin4.1%-7.7pp

Net margin1.5%-7.0pp

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity1.5%-6.4pp

Debt / equity0.9×+0.3×

Current ratio3.4×+0.6×

Segments

By product

See full

Neurosurgery$205.5M-0.1%

Wound Reconstruction$87.7M-3.8%

Instruments$54.5M-16.4%

ENT$41.7M+371%

Private Label$28.7M+50.2%

By geography

See full

Asia Pacific$46.0M-3.7%

Europe$40.7M+8.6%

Versus estimates

Revenue

Q1 2026$391.9MBeat by $10.1M Q4 2025$434.9MBeat by $5.3M Q3 2025$402.1MMiss by $27.6M Q2 2025$415.6MBeat by $1.3M Q1 2025$382.7MMiss by $19.9M Q4 2024$442.6MBeat by $30.9M

Diluted EPS

Q1 2026$0.54Beat by $0.13 Q4 2025$0.83Beat by $0.04 Q3 2025$0.54Beat by $0.11 Q2 2025$0.45Beat by $0.02 Q1 2025$0.41Miss by $0.02 Q4 2024$0.97Beat by $0.11

Ask the moment Integra LifeSciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Integra LifeSciences report Q2 2024 earnings?: Integra LifeSciences (IART) reported Q2 2024 earnings on July 29, 2024 before market open.
What were Integra LifeSciences's Q2 2024 revenue and EPS?: Integra LifeSciences reported revenue of $418.2M and eps of $0.63 for Q2 2024.
Did Integra LifeSciences beat estimates in Q2 2024?: Revenue beat the consensus estimate of $413.2M by $5.0M. EPS beat the consensus estimate of $0.62 by $0.01.
Where can I find Integra LifeSciences's Q2 2024 SEC filings?: You can read the 10-Q periodic report (0000917520-24-000094) directly on SEC EDGAR. The filing index links above go to sec.gov.